Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations

Slide collection

216,301-216,330 of 319,975

filter-aware
09
Pathward Financial | Investor Presentation Deck | 23 slidesPathward Financial | Investor Presentation Deck | 23 slides · Pathward
Pitch deck Investor relations Beat · Financials1 hit
10
Includes a legend for extraordinary items and a disclaimer regarding non-GAAP adjustments for FY 2022.Pathward Financial | Investor Presentation Deck | 23 slides · Pathward
Pitch deck Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
11
Peer group defined as commercial insured banks with assets between $3-10 billion.Pathward Financial | Investor Presentation Deck | 23 slides · Pathward
Pitch deck Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
12
The slide uses a Venn-like circular layout to present two key capital return metrics alongside qualitative operational targets.Pathward Financial | Investor Presentation Deck | 23 slides · Pathward
Pitch deck Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
13
The slide uses a grid of 8 metric cards, each with an icon, a headline number, and a descriptive sub-text.Pathward Financial | Investor Presentation Deck | 23 slides · Pathward
Pitch deck Investor relations 1 hit
14
The diagram uses a hub-and-spoke model to visualize the central position of Pathward in the financial ecosystem.Pathward Financial | Investor Presentation Deck | 23 slides · Pathward
Pitch deck Investor relations 1 hit
15
The slide uses a four-column layout to categorize business lines.Pathward Financial | Investor Presentation Deck | 23 slides · Pathward
Pitch deck Investor relations 1 hit
16
The chart highlights the acquisition of Crestmark in 2018.Pathward Financial | Investor Presentation Deck | 23 slides · Pathward
Pitch deck Investor relations 1 hit
17
The slide uses a horizontal arrow to imply a unified, integrated approach across these four domains.Pathward Financial | Investor Presentation Deck | 23 slides · Pathward
Pitch deck Investor relations 1 hit
18
Pathward Financial | Investor Presentation Deck | 23 slidesPathward Financial | Investor Presentation Deck | 23 slides · Pathward
Pitch deck Investor relations 1 hit
19
Standard financial disclosure slide for non-GAAP metrics.Pathward Financial | Investor Presentation Deck | 23 slides · Pathward
Pitch deck Investor relations 1 hit
20
The slide uses a hierarchical tree structure to represent the balance sheet components.Pathward Financial | Investor Presentation Deck | 23 slides · Pathward
Pitch deck Investor relations 1 hit
21
The slide uses two distinct waterfall diagrams to explain how Pathward secures its position in different financial products.Pathward Financial | Investor Presentation Deck | 23 slides · Pathward
Pitch deck Investor relations 1 hit
22
Pathward Financial | Investor Presentation Deck | 23 slidesPathward Financial | Investor Presentation Deck | 23 slides · Pathward
Pitch deck Investor relations 1 hit
23
Two-column reference glossary with bolded term headings and short paragraph definitions; no charts or imagery beyond the page footer and Pathward logo.Pathward Financial | Investor Presentation Deck | 23 slides · Pathward
Pitch deck Investor relations 1 hit
01
Slide 1
RayzeBio | IPO Presentation Deck | 41 slidesRayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
02
RayzeBio | IPO Presentation Deck | 41 slidesRayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
03
This is a standard IPO/follow-on offering summary table.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
04
The slide uses a structured table format to present key company metrics and status.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
05
RayzeBio | IPO Presentation Deck | 41 slidesRayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
06
The slide uses a Gantt-style visualization for drug development stages.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
07
Uses a visual metaphor of 'Outside in' vs 'Precise from within' to contrast the two treatment modalities.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
08
The slide uses a simple comparison framework to highlight clinical benefits.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
09
The slide uses a comparison framework to justify the use of alpha-emitting isotopes in targeted radiotherapy.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank Beat · Problem1 hit
10
The slide uses a chronological progression of therapeutic classes (Targeted, Immuno-oncology, ADCs, Cell Therapy) leading to RPT.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank Beat · ProblemLoop · Why Now1 hit
11
The slide uses a comparison table to validate the market potential of the radiopharmaceutical space by highlighting a competitor's success.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank Beat · ProblemLoop · Why Now1 hit
12
The slide uses a process flow diagram to show the standard of care progression for two types of NETs.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
13
The slide uses a Kaplan-Meier curve to contrast Lutathera against a control group, highlighting the clinical limitation of the current standard of care.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
14
The chart compares median progression vs median survival in months across three patient cohorts (Pancreatic, GI, Overall).RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
15
The slide uses a chemical structure comparison to illustrate the similarity in binder/chelator while highlighting the difference in radioisotope.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank Beat · Solution1 hit